National Institute of Virology develops 1st indigenous antibody detection kit for covid-19: Harsh Vardhan
4 years, 7 months ago

National Institute of Virology develops 1st indigenous antibody detection kit for covid-19: Harsh Vardhan

Live Mint  

The National Institute of Virology at Pune has successfully developed the first indigenous antibody detection kit for covid-19 that will play a critical role in surveillance for coronavirus infection, Union Health Minister Harsh Vardhan said on Sunday. The Indian Council of Medical Research -National Institute of Virology at Pune has developed and validated the indigenous IgG ELISA test “COVID KAVACH ELISA” for antibody detection for COVID-19, an official statement said. “The robust indigenous IgG ELISA test for antibody detection developed by ICMR-NIV, Pune will play a critical role in surveillance of proportion of population exposed to SARS-CoV-2 Coronavirus infection," Vardhan was quoted as in the statement. The scientists at ICMR-NIV, Pune, have enthusiastically worked to develop and validate the completely indigenous IgG ELISA test for antibody detection for SARS-CoV-2, the statement said.

India Test Indian Indigenous Pune Niv Kit Vardhan Igg Icmr Elisa National Institute Antibody National Institute Of Virology  kit  institute  test  statement  virology  covid19  elisa  harsh  detection  antibody  vardhan  national  develops  pune  indigenous  sarscov2

History of this topic

Nipah virus outbreak: Kerala gets antibody, mobile lab to combat the virus
1 year, 3 months ago

Nipah virus outbreak: Kerala gets antibody, mobile lab to combat the virus

Live Mint  

The Indian Council of Medical Research Thursday delivered the monoclonal antibody to Kozhikode requested by Kerala to combat the Nipah outbreak in the district, PTI reported. The report said a five-member central team comprising experts from the National Centre for Disease Control, RML Hospital and NIMHANS has been stationed in Kerala to take stock of the situation and assist the …

Continue COVID-19 testing to check emergence of new virus variants: WHO chief
1 year, 4 months ago

Continue COVID-19 testing to check emergence of new virus variants: WHO chief

The Hindu  

Warning that many countries aren’t testing enough and that new SARS-CoV-2 virus variants may emerge, Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, on Wednesday said that testing and being vigilant is vital in continuing the fight against COVID-19. “While COVID is now behind us and India did its best during the time, we can expect new and more …

MMC’s VRDL gets NABL certification
1 year, 5 months ago

MMC’s VRDL gets NABL certification

The Hindu  

The Viral Research and Diagnostic Laboratory of the Institute of Microbiology, Madras Medical College, has obtained National Accreditation Board for Testing and Calibration Laboratories certification. Chikungunya IgM, Dengue IgM, Epstein-Barr-virus IgM, Hepatitis A virus IgM, Hepatitis B virus, Rotavirus IgM, Japanese Encephalitis IgM and Dengue NS1 Antigen were tested by ELISA method, while Zika virus, influenza A virus, influenza B …

ICMR identifies biomarkers to diagnose severity, predict recovery of Covid-19
1 year, 11 months ago

ICMR identifies biomarkers to diagnose severity, predict recovery of Covid-19

Hindustan Times  

Mumbai: The National Institute For Research In Reproductive and Child Health of the Indian Council of Medical Research, and Brihanmumbai Municipal Corporation, have identified biomarkers that could help diagnose the severity of Covid-19 through a blood test. In 2021, two separate studies were taken up by the institute on a small cohort of Covid positive blood samples, the results of …

Chinese scientists develop prototype tool to test COVID-19 in 4 mins
2 years, 11 months ago

Chinese scientists develop prototype tool to test COVID-19 in 4 mins

China Daily  

BEIJING -- Chinese scientists have developed a molecular system that can provide COVID-19 testing results in less than four minutes. A research team from Shanghai-based Fudan University mentioned this portable prototype device in a study published recently in the journal Nature Biomedical Engineering, saying it can detect the traces of COVID-19-related genetic material quickly and accurately. The device is an …

New testing kit able to detect 15 strains of novel coronavirus
2 years, 11 months ago

New testing kit able to detect 15 strains of novel coronavirus

China Daily  

Guo Yong, professor at Tsinghua's School of Medicine, talks about the new COVID-19 testing kit on camera. China approved a new COVID-19 testing kit on Saturday that can accurately diagnose 15 common strains of the novel coronavirus, including the Delta and Omicron variants, according to kit developer Tsinghua University. The kit, which was approved by the National Medical Products Administration, …

ICMR approves India-made kit to detect Omicron
3 years ago

ICMR approves India-made kit to detect Omicron

The Hindu  

The Indian Council of Medical Research has approved a testing kit for detecting the Omicron variant of the SARS-CoV-2 coronavirus. Responsibility for batch-to-batch consistency lies with the manufacturer.” The kit currently in use to detect Omicron in India has been developed by the U.S.-based scientific instrumentation company Thermo Fisher. India’s COVID-19 tally continued its rise on Tuesday with the country …

Covovax Approval to Strengthen Immunization Efforts in India, Lower, Middle Income Countries: SII
3 years ago

Covovax Approval to Strengthen Immunization Efforts in India, Lower, Middle Income Countries: SII

News 18  

Vaccine major Serum Institute of India on Tuesday said the approval for the COVID-19 vaccine 'Covovax' would strengthen immunization initiatives across India and various lower and middle income countries across the world. He was responding to Union Health Minister Mansukh Mandaviya's announcement that the Central Drug Authority, the Central Drugs Standard Control Organisation, has approved the SII's vaccine Covovax for …

ICMR designs kit for Omicron detection; invites EOI from manufacturers for its commercialisation
3 years ago

ICMR designs kit for Omicron detection; invites EOI from manufacturers for its commercialisation

The Hindu  

The Indian Council of Medical Research has designed a diagnostic kit for detection of Omicron variant of the coronavirus and has invited Expression of Interest from in vitro diagnostics kit manufacturers for undertaking transfer of technology for its development and commercialisation. ICMR is lawfully entitled to enter into any form of non-exclusive license agreements with selected manufacturer/manufacturers, including transfer of …

ICMR approves indigenously developed kit to detect current COVID-19 variants
3 years ago

ICMR approves indigenously developed kit to detect current COVID-19 variants

The Hindu  

The CoviDelta diagnostics kit developed indigenously by Pune-based GenePath Diagnostics has been approved by the Indian Council of Medical Research, company sources said on Friday. The kit detects all current variants of COVID-19 and flags presumptive Delta and Omicron variants in a single test, said Dr. Nickhil Jakatdar, CEO, GenePath Diagnostics. “This kit is capable of detecting all important COVID-19 …

ICMR team designs kit to detect Omicron variant in 2 hours
3 years ago

ICMR team designs kit to detect Omicron variant in 2 hours

Hindustan Times  

The Indian Council of Medical Research has designed a testing kit that will be able to detect the Omicron variant of the coronavirus in a couple of hours, a report has said. A team of scientists of the Regional Medical Research Centre for the Northeast region led by scientist Dr Biswajyoti Borkakoty has developed the testing kit, which can detect …

Testing Times: All That You Need to Know about the Various Diagnostic Tools for Covid, Dengue, Zika
3 years, 1 month ago

Testing Times: All That You Need to Know about the Various Diagnostic Tools for Covid, Dengue, Zika

News 18  

Suggested to undergo RT-PCR tests but this time not for detection of Covid-19? News18.com spoke to medical experts with the aim to understand which tests are used for the detection of Covid-19, Zika, dengue and chikungunya, and how they work. RT-PCR tests Under molecular testing or RT-PCR technology, the virus is first extracted from blood samples or nose or throat …

Covid-19 Antibodies Found in 66% of Tamil Nadu's Population, Indicates Serosurvey
3 years, 5 months ago

Covid-19 Antibodies Found in 66% of Tamil Nadu's Population, Indicates Serosurvey

News 18  

At least 66.2 per cent of Tamil Nadu’s population has developed antibodies to Covid-19, a serosurvey conducted in July on over 26,000 samples has revealed. The third Tamil Nadu Cross Sectional Serosurvey also showed that among the 26,610 samples tested, 17,624 individuals had IgG antibodies against coronavirus. While the overall seroprevalence was 66.2 per cent, the highest seropositivity was observed …

Two-thirds of Indians have antibodies, shows ICMR survey - The Hindu
3 years, 5 months ago

Two-thirds of Indians have antibodies, shows ICMR survey - The Hindu

The Hindu  

While two-thirds of the general population had SARS-CoV-2 antibodies, a third does not have antibodies, making approximately 40 crore people still vulnerable to infections, Indian Council of Medical Research Director General Balram Bhargava said on Tuesday. Presenting the results of the fourth national COVID serosurvey, Dr. Bhargava said States, districts and areas without antibodies run the risk of infection waves. …

Two-thirds of Indians Have Covid Antibodies, Another 40 Crore Still Vulnerable to Infection: Govt
3 years, 5 months ago

Two-thirds of Indians Have Covid Antibodies, Another 40 Crore Still Vulnerable to Infection: Govt

News 18  

Around 40 crore people are still vulnerable to COVID-19 infection as a nationwide survey found two-thirds of the country’s population aged above six to have SARS-CoV-2 antibodies, the government said on Tuesday as it stressed there is no room for complacency in the fight against the pandemic. Addressing a press conference, a senior official said two-thirds or 67.6 per cent …

India’s Covaxin effectively neutralises Delta variant of Covid, says U.S.' health research institute
3 years, 6 months ago

India’s Covaxin effectively neutralises Delta variant of Covid, says U.S.' health research institute

The Hindu  

India’s Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralises both Alpha and Delta variants of coronavirus, the U.S.’ National Institute of Health has said. The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 and …

Covaxin effectively neutralises both Alpha, Delta variants of Covid-19: US' top health institute
3 years, 6 months ago

Covaxin effectively neutralises both Alpha, Delta variants of Covid-19: US' top health institute

India TV News  

India's Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralises both Alpha and Delta variants of coronavirus, the US' National Institute of Health has said. The NIH said results of two studies of blood serum from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 and …

India achieves milestone of conducting 40 crore COVID-19 tests: ICMR
3 years, 6 months ago

India achieves milestone of conducting 40 crore COVID-19 tests: ICMR

The Hindu  

India has achieved the milestone of conducting 40 crore COVID-19 tests, with the average of more than 18 lakh tests per day in the month of June, the ICMR said on Saturday, June 26, 2021. ICMR has been enhancing COVID-19 testing capability across the country by expanding and diversifying testing capacity by leveraging technology and facilitating innovation in affordable diagnostic …

The Science Behind Covid-19 Vaccines Approved by India - News18
3 years, 6 months ago

The Science Behind Covid-19 Vaccines Approved by India - News18

News 18  

Indian drugmaker Zydus Cadila said on Thursday it has applied to the country’s drug regulator for emergency use approval of its Covid-19 vaccine, which showed a 66.6% efficacy against positive cases in an interim analysis. The development comes a day after Cipla on Tuesday received the approval from the Drugs Controller General of India to import Moderna’s coronavirus vaccine for …

Now, Test Yourself for Covid in 15 Minutes at Home: 'CoviSelf' to be Available at Pharmacies, Online
3 years, 7 months ago

Now, Test Yourself for Covid in 15 Minutes at Home: 'CoviSelf' to be Available at Pharmacies, Online

News 18  

A Pune-based diagnostics firm has commenced the shipping of Covid-19 self-test kits, called ‘CoviSelf’. The ICMR had in May granted approval to the firm for its new self-use rapid home-test kit for Covid-19 with results available in just 15 minutes. Named ‘CoviSelf’, the country’s first Covid-19 home-test kit, priced at Rs 250, has been developed by Mylab Discovery Solutions. Mylab …

DRDO develops Covid-19 antibody detection kit 'DIPCOVAN'
3 years, 7 months ago

DRDO develops Covid-19 antibody detection kit 'DIPCOVAN'

India TV News  

The Defence Research and Development Organisation has unveiled its yet another achievement which will aide country's ongoing fight against the COVID-19 pandemic. DRDO's Defence Institute of Physiology and Allied Sciences has developed an antibody detection-based kit 'DIPCOVAN', the DIPAS-VDx COVID 19 IgG Antibody Microwell ELISA for sero-surveillance. The kit has been developed in association with Vanguard Diagnostics Pvt Ltd, a …

COVID-19 home test kit approved; symptomatic people testing negative should go for RT-PCR, says ICMR
3 years, 7 months ago

COVID-19 home test kit approved; symptomatic people testing negative should go for RT-PCR, says ICMR

Firstpost  

The ICMR said the RAT kits should be used only on symptomatic individuals and on immediate contacts of laboratory-confirmed positive cases New Delhi: The Indian Council of Medical Research on Wednesday approved a home-based rapid antigen testing kit for COVID-19, which it advised should be used only on symptomatic individuals and on immediate contacts of laboratory-confirmed positive cases. The country’s …

New RT-PCR kit 97.3% sensitive in detecting Covid mutants: All you need to know
3 years, 7 months ago

New RT-PCR kit 97.3% sensitive in detecting Covid mutants: All you need to know

Hindustan Times  

Union health minister Dr Harsh Vardhan on Wednesday said the new RT-PCR kit developed by Sree Chitra Turunal Institute for Medical Science and Technology under the department of sciences and technology is 97.3 per cent sensitive. Union minister Harsh Vardhan on Wednesday tweeted about the new RT-PCR kit. ICMR okays new RT-PCR kit with ‘high accuracy’ Here is all you …

Home testing kit for Covid-19 gets ICMR nod. Watch how to test yourself
3 years, 7 months ago

Home testing kit for Covid-19 gets ICMR nod. Watch how to test yourself

India Today  

ICMR has approved a home-based testing kit for Covid-19. It is a home rapid antigen testing kit, which is advisable only for symptomatic individuals and people who have come in contact with lab-tested Covid positive people. WATCH HOW TO TEST USING THE SELF-TESTING KIT So far, only one company --- Mylab Discovery Solutions Ltd --- has been approved in India. …

ICMR okays new RT-PCR kit with ‘high accuracy’
3 years, 7 months ago

ICMR okays new RT-PCR kit with ‘high accuracy’

Hindustan Times  

Using a gene that is least likely to mutate, the Sree Chitra Tirunal Institute for Medical Sciences and Technology in Kerala have developed a new RT-PCR kit that they say has a higher accuracy in detecting Covid-19. RT-PCR tests amplify the genetic material of the virus found on swab samples, extract it and check for specific fragments to give a …

From Testing Kits to Anti-COVID Gears: What Education Institutes Contributed to Fight Against Coronavirus
3 years, 7 months ago

From Testing Kits to Anti-COVID Gears: What Education Institutes Contributed to Fight Against Coronavirus

News 18  

As India is battling COVID-19, the universities and higher education institutes across the country have joined the fight against the pandemic. Let’s look at what Education Institutes have Contributed to India’s Fight Against COVID-19 IIM Lucknow’s Information Portal: Amrita Singh, a software engineer and a student of IIM Lucknow has developed a web portal offering a list of initiatives to …

ICMR Issues New Guidelines For RT-PCR Testing Amid Second Coronavirus Wave
3 years, 8 months ago

ICMR Issues New Guidelines For RT-PCR Testing Amid Second Coronavirus Wave

ABP News  

The second wave of Coronavirus is turning out to be deadly with India witnessing an unprecedented upsurge of COVID-19 cases and deaths every day. As per the ICMR Advisory, if a person has once tested Coronavirus positive during the Rapid Antigen Test or RT-PCR test, then there is no need for that individual to undergo RT-PCR test again. READ | …

Serum institute begins Covovax clinical trials in India, vaccine may launch by September
3 years, 9 months ago

Serum institute begins Covovax clinical trials in India, vaccine may launch by September

Firstpost  

Serum Institute of India CEO Adar Poonawalla on Saturday said clinical trials of COVID-19 vaccine Covovax have begun in India and the company hopes to launch it by September this year In August 2020, US-based vaccine maker Novavax, Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and …

Serum Institute's 2nd COVID-19 vaccine likely to be launched in September
3 years, 9 months ago

Serum Institute's 2nd COVID-19 vaccine likely to be launched in September

India TV News  

Serum Institute of India, the world's biggest Covid-19 vaccine maker, is hopeful of launching its second vaccine for coronavirus — Covovax — by September this year, CEO Adar Poonawalla announced on Saturday. "Covovax trials finally begin in India; the vaccine is made through a partnership with Novavax and Serum Institute of India," said Adar Poonawalla. the CEO of world's biggest …

Coronavirus | Clinical trials indicate India’s vaccines will be effective against COVID-19 variants: ICMR
3 years, 10 months ago

Coronavirus | Clinical trials indicate India’s vaccines will be effective against COVID-19 variants: ICMR

The Hindu  

Indian Council of Medical Research Director General Dr Balram Bhargava has said interim results of the ongoing clinical trials indicated that the indigenous Covid-19 vaccines would be effective against the mutated virus strains reported from the United Kingdom, South Africa and Brazil. In the case of the variants from South Africa and Brazil, efforts were on to isolate the mutated …

Coronavirus | Serum Institute of India, UNICEF enter into long-term supply pact for COVID-19 vaccines
3 years, 11 months ago

Coronavirus | Serum Institute of India, UNICEF enter into long-term supply pact for COVID-19 vaccines

The Hindu  

The Serum Institute of India and UNICEF have entered into a long-term supply agreement for the AstraZeneca/Oxford and the Novavax vaccines, with the UN children’s agency saying it will have access to up to 1.1 billion doses of vaccines for around 100 countries. While Oxford-AstraZeneca's Covishield is being manufactured by Pune-based Serum Institute, and the Novavax is being produced by …

Novavax Vaccine’s Nearly 90% Efficacy Sparks Hope in India as Serum Institute Seeks Local Trial Nod
3 years, 11 months ago

Novavax Vaccine’s Nearly 90% Efficacy Sparks Hope in India as Serum Institute Seeks Local Trial Nod

News 18  

US-based Novavax’s Covid-19 vaccine candidate has shown nearly 90 per cent efficacy and the ability to work against the UK and South African variants of the virus. The company, in a statement, said its Covid-19 vaccine demonstrated 89.3 per cent efficacy in UK Phase-3 trial. “Nvx-cov2373, the protein-based Covid-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of …

Serum Institute seeks approval to conduct local trial for Novavax Covid vaccine
3 years, 11 months ago

Serum Institute seeks approval to conduct local trial for Novavax Covid vaccine

Live Mint  

The world's largest vaccine manufacturer, the Serum Institute of India, has sought the Drugs Controller General of India's permission to conduct a small domestic trial of the Novavax coronavirus vaccine that was found to be 89.3% effective in a UK trial, its Chief Executive Officer Adar Poonawalla told news agency Reuters on Friday. Earlier today, Novavax said that its Covid-19 …

Covaxin jab effective against UK variant of coronavirus, claims study
3 years, 11 months ago

Covaxin jab effective against UK variant of coronavirus, claims study

Firstpost  

Hyderabad: Covaxin, developed by Bharat Biotech, has the ability to neutralise the UK variant of the coronavirus, according to a preprint review by bioRxiv, a free online archive and distribution service for unpublished preprints in the life sciences. Bharat Biotech performed the plaque reduction neutralisation test using sera collected from the 26 recipients of Covaxin and tested them against the …

4 more Covid vaccines in different stages of trial: Serum Institute of India
3 years, 11 months ago

4 more Covid vaccines in different stages of trial: Serum Institute of India

India TV News  

Apart from Covishield, the Serum Institute of India is working on four more vaccines against the novel coronavirus, according to Suresh Jadhav, executive director at one of the world's largest vaccine manufacturers. Jadhav informed during a webinar that the firm has been working on five vaccines against the novel coronavirus, including the Covishield which got approval for emergency use roll-out …

Coronavirus | IMA endorses safety, efficacy of both vaccines cleared by India
3 years, 11 months ago

Coronavirus | IMA endorses safety, efficacy of both vaccines cleared by India

The Hindu  

The Indian Medical Association has requested all its 3.5 lakh members in 1,800 local branches to voluntarily get vaccinated first to show that the vaccines approved in India are safe and efficacious. Our modern medicine doctors will vouch for the safety, quality and professionalism in this difficult time and support the emergency approval for the usage of vaccines,” said the …

COVID-19 vaccine race: Where they stand currently
4 years ago

COVID-19 vaccine race: Where they stand currently

India TV News  

Almost a year into the COVID-19 pandemic, about 200 vaccine candidates are in the works and 10 have been either approved by several countries or are under limited emergency use. Given as two doses, three weeks apart, the viral proteins in the vaccine activate the immune system and prepare people for future infections with the actual infectious virus. Administered as …

India sees 20 more cases of UK Covid-19 strain, total 58
4 years ago

India sees 20 more cases of UK Covid-19 strain, total 58

India Today  

As many as 58 persons have tested positive for the new UK variant of SARS-CoV-2 in India so far, the Union Health Ministry said on Tuesday. “The total number of cases infected with the new strain of the novel Coronavirus first reported in the UK now stands at 58,” Union Health Ministry was quoted as saying by news agency ANI. …

Coronavirus | COVID-19 vaccination preparations done, rollout in near future: NITI Aayog member V.K. Paul
4 years ago

Coronavirus | COVID-19 vaccination preparations done, rollout in near future: NITI Aayog member V.K. Paul

The Hindu  

India should be able to roll out its COVID-19 vaccination programme in the “near future” as its preparation is ready and robust, NITI Aayog member V.K. Paul said in an exclusive interview with The Hindu, adding that at least 12 countries have specified their interest in India’s indigenous COVID-19 vaccine, Covaxin. Coronavirus | Drug Controller General approves Covishield and Covaxin …

Coronavirus | India approves COVID-19 vaccines Covishield and Covaxin for emergency use
4 years ago

Coronavirus | India approves COVID-19 vaccines Covishield and Covaxin for emergency use

The Hindu  

Vaccines by Bharat Biotech and Serum Institute of India were formally approved by the Central Drugs and Standards Committee on Sunday. However, a press statement by the Health Ministry said the vaccine’s efficacy in Indian volunteers was “comparable” to that tested in overseas trials. Bharat Biotech whose vaccine candidate was being tested in large phase-3 efficacy trial in India, has …

WHO welcomes India's coronavirus vaccine approval, says will help intensify fight against Covid
4 years ago

WHO welcomes India's coronavirus vaccine approval, says will help intensify fight against Covid

India Today  

The World Health Organisation on Sunday welcomed India's decision to give approval to Covid-19 vaccines for emergency use authorisation and said the move will "intensify and strengthen" the fight against the coronavirus pandemic. This decision taken today by India will help intensify and strengthen the fight against Covid-19 pandemic in the Region," Dr Poonam Khetrapal Singh, the regional director, WHO …

Coronavirus | Data on Covaxin phase-3 trials submitted to DCGI: Bharat Biotech
4 years ago

Coronavirus | Data on Covaxin phase-3 trials submitted to DCGI: Bharat Biotech

The Hindu  

Bharat Biotech in a statement issued on Saturday said the publication of its COVID vaccine ’s phase II trial data is undergoing the peer review process and that as a part of the regulatory guidelines all data has been submitted to the DCGI and CDSCO. The firm said that product development and clinical trial data for Covaxin has so far …

COVID-19 vaccine: Emergency approval not recommended for Covaxin; panel asks more data
4 years ago

COVID-19 vaccine: Emergency approval not recommended for Covaxin; panel asks more data

Live Mint  

A subject expert committee set up by Drugs Controller General of India to examine COVID-19 vaccine proposals, recommended 'interim efficacy analysis for Covaxin'. "After detailed deliberation, the committee recommended that the firm should try to expedite the recruitment and may perform interim efficacy analysis for further consideration of restricted emergency use approval," an official source told PTI. The SEC met …

Indian vaccine Covaxin has drawn global attention: ICMR
4 years ago

Indian vaccine Covaxin has drawn global attention: ICMR

Hindustan Times  

The Indian Council of Medical Research has said that the Indian vaccine against Covid-19, Covaxin, has drawn global attention. ICMR has said that Covaxin has drawn global attention In a tweet, the ICMR said, “India’s indigenous vaccine against #Covid19 Covaxin-a product of ICMR-Bharat Biotech collaboration, achieves remarkable feat. Data generated from within India underlines impressive safety and immunogenicity profile of …

Indian Covid-19 vaccine Covaxin has drawn global attention: ICMR
4 years ago

Indian Covid-19 vaccine Covaxin has drawn global attention: ICMR

Live Mint  

New Delhi: The Indian Council of Medical Research has said that the Indian vaccine against the novel coronavirus, Covaxin, has drawn global attention. The ICMR said, "Encouraging Phase I and Phase II COVAXIN trial results have paved the path for Phase III Clinical Trial in India, which is currently ongoing at 22 sites." Covaxin, Bharat Biotech’s coronavirus vaccine candidate, has …

Immunity induced by COVID-19 vaccine expected to protect against new variants: Moderna
4 years ago

Immunity induced by COVID-19 vaccine expected to protect against new variants: Moderna

India TV News  

Moderna Inc on Wednesday said that it expects that the immunity induced by its COVID-19 vaccine would be protective against the new coronavirus variants found in the United Kingdom. A press release issued by the vaccine company reads, "While we plan to run tests to confirm the activity of the vaccine against any strain, the broad range of potential neutralizing …

New Covid-19 strain not detected in samples tested in India: ICMR-NARI director
4 years ago

New Covid-19 strain not detected in samples tested in India: ICMR-NARI director

Live Mint  

Pune: Mutant strain of coronavirus found in the United Kingdom was not seen in the samples tested from various parts of India, Dr Samiran Panda, director of ICMR-National AIDS Research Institute said on Tuesday. Speaking to ANI, Dr Panda said, "We have tested samples collected from the various parts of the country and haven't seen the mutant strain found in …

Coronavirus | Bharat Biotech ropes in 13,000 volunteers for Covaxin phase-III trials
4 years ago

Coronavirus | Bharat Biotech ropes in 13,000 volunteers for Covaxin phase-III trials

The Hindu  

Vaccine maker Bharat Biotech has recruited 13,000 of the 26,000 volunteers for the ongoing phase-III clinical trials of its COVID-19 vaccine candidate Covaxin. This pro-vaccine public health volunteerism is a morale boost for us to achieve our milestone target of 26,000 soon – Thank you volunteers,” said Suchitra Ella, Joint MD, Bharat Biotech. A release from the company said the …

Covid vaccine update: US panel endorses Moderna vaccine, AIIMS unable to find volunteers for Covaxin trials
4 years ago

Covid vaccine update: US panel endorses Moderna vaccine, AIIMS unable to find volunteers for Covaxin trials

India Today  

Coronavirus vaccine update: After rolling out the Pfizer coronavirus vaccine, US is now looking to approve the Moderna vaccine as well as coronavirus cases surge in the nation. Meanwhile in India, AIIMS-Delhi is reportedly finding it difficult to get enough volunteers for the Phase 3 trials of Covaxin, a Covid-19 vaccine candidate being developed by Hyderabad-based Bharat Biotech. US FDA …

Scientists develop new coronavirus antibody test that gives results in 20 minutes
4 years, 1 month ago

Scientists develop new coronavirus antibody test that gives results in 20 minutes

India Today  

A new coronavirus antibody test has been developed by scientists that can give results within 20 minutes. The new method, called biolayer interferometry immunosorbent assay, provides complete quantitative results in less than 20 minutes. "Our assay is as sensitive if not better than other assays in detecting low levels of antibodies, and the specificity is as good as the best …

Discover Related